SUMATRIPTAN SUCCINATE

SUMATRIPTAN SUCCINATE was reported 25894 times

SUMATRIPTAN SUCCINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CERVICOGENIC HEADACHE 21 0.1544
1 MEDICATION OVERUSE HEADACHE 131 0.1530
2 IIIRD NERVE PARESIS 27 0.1484
3 POSTNATAL GROWTH RESTRICTION 16 0.1221
4 PINEAL GLAND CYST 17 0.1214
5 MIGRAINE WITHOUT AURA 30 0.1000
6 CORONARY ARTERY DISSECTION 61 0.0710
7 DRUG SPECIFIC ANTIBODY 86 0.0628
8 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 119 0.0602
9 POST-TRAUMATIC NECK SYNDROME 45 0.0556
10 SOFT TISSUE INJURY 42 0.0555
11 CLUSTER HEADACHE 64 0.0468
12 STERNAL FRACTURE 42 0.0340
13 CEREBRAL VASOCONSTRICTION 25 0.0338
14 ARTERIOSPASM CORONARY 117 0.0291
15 VASOSPASM 24 0.0261
16 ENDOMETRIOSIS 124 0.0260
17 RENAL APLASIA 18 0.0256
18 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 63 0.0237
19 PULMONARY ARTERY STENOSIS CONGENITAL 17 0.0233
20 FOETAL HEART RATE ABNORMAL 21 0.0227
21 BRUGADA SYNDROME 23 0.0222
22 TRANSIENT GLOBAL AMNESIA 16 0.0222
23 DRUG-DISEASE INTERACTION 16 0.0218
24 DEVICE DEPLOYMENT ISSUE 278 0.0217
25 OBSTRUCTIVE SLEEP APNOEA SYNDROME 31 0.0212
26 EXTENSOR PLANTAR RESPONSE 19 0.0206
27 CENTRAL OBESITY 15 0.0203
28 LIBIDO INCREASED 40 0.0197
29 PITUITARY TUMOUR BENIGN 32 0.0196
30 MIGRAINE 1871 0.0196
31 NEONATAL RESPIRATORY DISTRESS 18 0.0191
32 MICROCEPHALY 24 0.0187
33 COLITIS ISCHAEMIC 126 0.0187
34 RENAL INFARCT 27 0.0186
35 CLONUS 51 0.0186
36 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 25 0.0185
37 CRANIOSYNOSTOSIS 16 0.0185
38 PRINZMETAL ANGINA 17 0.0171
39 MIGRAINE WITH AURA 46 0.0169
40 BINGE EATING 18 0.0167
41 PRE-EXISTING CONDITION IMPROVED 104 0.0166
42 ABORTION MISSED 21 0.0165
43 HOSTILITY 42 0.0165
44 PERSONALITY DISORDER 43 0.0164
45 GESTATIONAL HYPERTENSION 21 0.0163
46 CLEFT LIP AND PALATE 17 0.0152
47 OESOPHAGEAL SPASM 28 0.0152
48 INFECTION REACTIVATION 17 0.0148
49 SECONDARY ADRENOCORTICAL INSUFFICIENCY 22 0.0146
50 PRODUCT COMPLAINT 364 0.0144
51 TENSION HEADACHE 61 0.0142
52 HYPOTONIA NEONATAL 22 0.0141
53 CEREBRAL VENOUS THROMBOSIS 25 0.0138
54 SEROTONIN SYNDROME 238 0.0124
55 NIPPLE PAIN 24 0.0118
56 HYPERREFLEXIA 41 0.0118
57 SLEEP PARALYSIS 17 0.0116
58 STRESS CARDIOMYOPATHY 65 0.0112
59 SOMNAMBULISM 72 0.0110
60 SWOLLEN TONGUE 334 0.0107
61 SMALL FOR DATES BABY 53 0.0107
62 ANGLE CLOSURE GLAUCOMA 27 0.0106
63 RESPIRATORY DISORDER NEONATAL 17 0.0105
64 LABELLED DRUG-DRUG INTERACTION ISSUE 15 0.0104
65 PRODUCT PHYSICAL ISSUE 208 0.0103
66 PRODUCT ADMINISTRATION INTERRUPTED 79 0.0101
67 FOETAL GROWTH RESTRICTION 61 0.0100
68 POST-TRAUMATIC STRESS DISORDER 64 0.0095
69 INHIBITORY DRUG INTERACTION 15 0.0095
70 CONCUSSION 73 0.0094
71 DISINHIBITION 15 0.0093
72 HYPOGLYCAEMIA NEONATAL 15 0.0093
73 PHARYNGEAL SWELLING 89 0.0091
74 NARCOLEPSY 17 0.0090
75 NASAL OEDEMA 16 0.0088
76 SLEEP TALKING 15 0.0088
77 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 29 0.0087
78 RENAL TUBULAR ACIDOSIS 19 0.0087
79 THROAT TIGHTNESS 235 0.0087
80 MAJOR DEPRESSION 63 0.0086
81 AURA 16 0.0086
82 THERAPEUTIC PRODUCT EFFECT VARIABLE 33 0.0085
83 IRON DEFICIENCY 38 0.0084
84 INFUSION SITE BRUISING 18 0.0083
85 REBOUND ACID HYPERSECRETION 25 0.0083
86 MATERNAL EXPOSURE DURING BREAST FEEDING 33 0.0081
87 FEAR OF DEATH 18 0.0080
88 IMPAIRED GASTRIC EMPTYING 108 0.0079
89 SLEEP APNOEA SYNDROME 151 0.0079
90 OESOPHAGEAL PAIN 31 0.0078
91 LICHEN PLANUS 18 0.0078
92 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
93 MUSCLE CONTRACTIONS INVOLUNTARY 27 0.0077
94 DEPRESSIVE SYMPTOM 27 0.0077
95 DEVICE FAILURE 115 0.0075
96 HYPERACUSIS 28 0.0075
97 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 127 0.0074
98 DEVICE MALFUNCTION 520 0.0074
99 NEEDLE ISSUE 213 0.0073
100 ANGIOEDEMA 314 0.0071
101 SLOW SPEECH 17 0.0070
102 SNORING 26 0.0069
103 HYPERPARATHYROIDISM SECONDARY 17 0.0068
104 HELICOBACTER INFECTION 69 0.0067
105 NEPHROGENIC ANAEMIA 30 0.0065
106 SELF-INJURIOUS IDEATION 27 0.0064
107 HEAD DISCOMFORT 113 0.0064
108 INFUSION SITE PRURITUS 20 0.0063
109 DEVICE DEFECTIVE 108 0.0062
110 MACULOPATHY 22 0.0062
111 FEELING OF BODY TEMPERATURE CHANGE 36 0.0061
112 MUSCLE TWITCHING 141 0.0061
113 THERAPEUTIC RESPONSE DELAYED 17 0.0061
114 DRUG INTOLERANCE 586 0.0061
115 TEMPOROMANDIBULAR JOINT SYNDROME 16 0.0060
116 FOETAL DEATH 30 0.0058
117 MOUTH SWELLING 33 0.0057
118 OPTIC ISCHAEMIC NEUROPATHY 22 0.0057
119 SWELLING FACE 368 0.0056
120 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 306 0.0056
121 ATRIAL SEPTAL DEFECT 46 0.0055
122 CHRONIC KIDNEY DISEASE 416 0.0055
123 INFUSION SITE HAEMORRHAGE 18 0.0055
124 GESTATIONAL DIABETES 26 0.0055
125 DEVICE ISSUE 478 0.0053
126 DYSPHONIA 311 0.0053
127 PHOTOPHOBIA 100 0.0053
128 AUTOIMMUNE THYROIDITIS 20 0.0053
129 PRODUCT QUALITY ISSUE 713 0.0052
130 ERYTHEMA NODOSUM 18 0.0051
131 EXPIRED DEVICE USED 17 0.0051
132 FIBROMYALGIA 124 0.0051
133 ATRIOVENTRICULAR BLOCK FIRST DEGREE 22 0.0051
134 BODY TEMPERATURE INCREASED 103 0.0050
135 SUICIDAL BEHAVIOUR 21 0.0050
136 RESTLESS LEGS SYNDROME 91 0.0050
137 PARAESTHESIA ORAL 72 0.0050
138 PANIC REACTION 36 0.0050
139 MIDDLE INSOMNIA 93 0.0050
140 TORSADE DE POINTES 39 0.0050
141 INFUSION SITE SWELLING 31 0.0049
142 DRUG SPECIFIC ANTIBODY PRESENT 32 0.0049
143 HYPERTONIA 28 0.0049
144 FEELING DRUNK 36 0.0048
145 POOR QUALITY SLEEP 104 0.0048
146 LYMPHOEDEMA 33 0.0048
147 LOCALISED OEDEMA 22 0.0047
148 MENINGITIS ASEPTIC 21 0.0047
149 TEMPERATURE INTOLERANCE 48 0.0046
150 TEARFULNESS 20 0.0046
151 SEASONAL ALLERGY 65 0.0046
152 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 19 0.0046
153 NECK PAIN 255 0.0046
154 MUSCLE TIGHTNESS 73 0.0045
155 VENTRICULAR FIBRILLATION 50 0.0045
156 OLIGOHYDRAMNIOS 15 0.0045
157 SUSPECTED SUICIDE 21 0.0045
158 HYPERPROLACTINAEMIA 29 0.0045
159 TROPONIN INCREASED 34 0.0045
160 TRISMUS 23 0.0044
161 DEPRESSION SUICIDAL 15 0.0043
162 MICTURITION DISORDER 15 0.0043
163 HEREDITARY ANGIOEDEMA 46 0.0043
164 INFUSION SITE PAIN 55 0.0043
165 BRUXISM 23 0.0043
166 UTERINE LEIOMYOMA 31 0.0042
167 ACUTE CORONARY SYNDROME 35 0.0042
168 TONSILLITIS 22 0.0042
169 BRAIN FOG 66 0.0042
170 PRE-ECLAMPSIA 20 0.0042
171 PAIN IN JAW 119 0.0042
172 FOOD ALLERGY 32 0.0041
173 DYSPHEMIA 18 0.0041
174 IMPAIRED QUALITY OF LIFE 59 0.0041
175 HORMONE LEVEL ABNORMAL 20 0.0041
176 FOETAL EXPOSURE DURING PREGNANCY 332 0.0041
177 MULTIPLE ALLERGIES 32 0.0041
178 PERIPHERAL COLDNESS 56 0.0041
179 APPLICATION SITE BURN 20 0.0041
180 INITIAL INSOMNIA 41 0.0040
181 MUSCLE SPASTICITY 49 0.0040
182 TRIGEMINAL NEURALGIA 16 0.0040
183 SENSORY LOSS 32 0.0040
184 ENURESIS 16 0.0040
185 BIPOLAR DISORDER 43 0.0040
186 PHOTOPSIA 25 0.0040
187 SYNOVITIS 71 0.0039
188 CHEST DISCOMFORT 402 0.0039
189 ROSACEA 18 0.0039
190 FEELING OF DESPAIR 18 0.0039
191 BLEPHAROSPASM 24 0.0038
192 EXPOSURE DURING PREGNANCY 236 0.0038
193 INFUSION SITE ERYTHEMA 32 0.0038
194 NIGHTMARE 131 0.0038
195 END STAGE RENAL DISEASE 69 0.0038
196 DISSOCIATION 29 0.0038
197 RIB FRACTURE 77 0.0037
198 PARAESTHESIA 587 0.0037
199 THERAPEUTIC PRODUCT EFFECT DELAYED 17 0.0037
200 PAROSMIA 28 0.0037
201 LIVE BIRTH 31 0.0037
202 ACUTE MYOCARDIAL INFARCTION 108 0.0037
203 SINUS TACHYCARDIA 52 0.0037
204 PHARYNGEAL OEDEMA 56 0.0036
205 FACIAL PARALYSIS 31 0.0036
206 TENSION 22 0.0036
207 SCREAMING 23 0.0036
208 FACIAL PAIN 32 0.0036
209 FOREIGN BODY IN REPRODUCTIVE TRACT 32 0.0036
210 PRODUCT SUBSTITUTION ISSUE 206 0.0036
211 AFFECT LABILITY 34 0.0035
212 HEADACHE 2212 0.0035
213 APHASIA 106 0.0035
214 PRODUCT DOSE OMISSION ISSUE 1031 0.0035
215 DIPLOPIA 91 0.0035
216 HYSTERECTOMY 30 0.0035
217 TINNITUS 159 0.0035
218 NEUROLEPTIC MALIGNANT SYNDROME 41 0.0035
219 METABOLIC DISORDER 20 0.0034
220 UMBILICAL HERNIA 16 0.0034
221 MELANOCYTIC NAEVUS 15 0.0034
222 INSURANCE ISSUE 52 0.0034
223 SKIN ABRASION 16 0.0034
224 VITAMIN D DEFICIENCY 33 0.0034
225 PREMATURE LABOUR 19 0.0034
226 SUPRAVENTRICULAR TACHYCARDIA 32 0.0033
227 SPINAL OPERATION 41 0.0033
228 SEDATION 87 0.0033
229 HOT FLUSH 249 0.0033
230 BREAST PAIN 35 0.0033
231 UPPER-AIRWAY COUGH SYNDROME 27 0.0033
232 HYPERHIDROSIS 422 0.0033
233 INTESTINAL ISCHAEMIA 18 0.0033
234 PANIC ATTACK 119 0.0033
235 SUICIDAL IDEATION 298 0.0033
236 NEURALGIA 79 0.0032
237 EYELID PTOSIS 33 0.0032
238 DISTURBANCE IN ATTENTION 175 0.0032
239 VERTIGO 197 0.0032
240 COGNITIVE DISORDER 150 0.0032
241 PRODUCT LEAKAGE 18 0.0032
242 LIMB DISCOMFORT 99 0.0032
243 SINUS HEADACHE 19 0.0032
244 FEELING COLD 89 0.0032
245 OPTIC NEURITIS 29 0.0032
246 ASTHMA 360 0.0032
247 DERMATITIS CONTACT 36 0.0032
248 ANAL ABSCESS 17 0.0032
249 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 147 0.0031
250 CHOLECYSTITIS CHRONIC 21 0.0031
251 PETIT MAL EPILEPSY 16 0.0031
252 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 17 0.0031
253 CHOKING SENSATION 17 0.0031
254 OBESITY 49 0.0031
255 PALPITATIONS 359 0.0031
256 DEPRESSION 697 0.0031
257 HYPOAESTHESIA 458 0.0031
258 ANXIETY 869 0.0031
259 CATATONIA 16 0.0030
260 VISUAL FIELD DEFECT 22 0.0030
261 MUCOUS STOOLS 15 0.0030
262 HYPERSENSITIVITY 553 0.0030
263 MICTURITION URGENCY 34 0.0030
264 PRODUCT DELIVERY MECHANISM ISSUE 16 0.0030
265 ECONOMIC PROBLEM 45 0.0030
266 ABORTION SPONTANEOUS 118 0.0029
267 GASTROOESOPHAGEAL REFLUX DISEASE 237 0.0029
268 EAR INFECTION 78 0.0029
269 EUPHORIC MOOD 30 0.0029
270 SENSORY DISTURBANCE 47 0.0029
271 EAR DISCOMFORT 30 0.0029
272 THERAPEUTIC RESPONSE UNEXPECTED 131 0.0029
273 NONSPECIFIC REACTION 16 0.0029
274 PERSONALITY CHANGE 27 0.0029
275 NEPHROLITHIASIS 133 0.0029
276 BRONCHITIS 214 0.0029
277 LIP SWELLING 96 0.0029
278 OROPHARYNGEAL DISCOMFORT 26 0.0029
279 FORMICATION 20 0.0029
280 PARALYSIS 41 0.0029
281 SINUSITIS 293 0.0029
282 SOMNOLENCE 575 0.0029
283 MACULAR OEDEMA 16 0.0029
284 ANHEDONIA 75 0.0029
285 DYSARTHRIA 107 0.0028
286 CYSTITIS 90 0.0028
287 NYSTAGMUS 15 0.0028
288 MATERNAL EXPOSURE DURING PREGNANCY 251 0.0028
289 ISCHAEMIC STROKE 50 0.0028
290 ANAL FISSURE 15 0.0028
291 COORDINATION ABNORMAL 39 0.0028
292 BRAIN INJURY 28 0.0028
293 GASTROINTESTINAL INFECTION 25 0.0028
294 CARPAL TUNNEL SYNDROME 39 0.0028
295 ATAXIA 33 0.0028
296 COLD SWEAT 49 0.0028
297 ANKLE FRACTURE 43 0.0028
298 CHEST PAIN 514 0.0028
299 MYOCLONUS 33 0.0028
300 DRUG EFFECT LESS THAN EXPECTED 41 0.0028
301 HYPERVENTILATION 16 0.0028
302 ARTHRITIS 217 0.0028
303 WRIST FRACTURE 33 0.0028
304 EYE PAIN 154 0.0027
305 ROTATOR CUFF SYNDROME 35 0.0027
306 PHOTOSENSITIVITY REACTION 45 0.0027
307 ADRENAL INSUFFICIENCY 33 0.0027
308 INJECTION SITE INJURY 15 0.0027
309 THERAPEUTIC RESPONSE DECREASED 164 0.0027
310 OSTEOPENIA 41 0.0027
311 CENTRAL NERVOUS SYSTEM LESION 37 0.0027
312 DECREASED ACTIVITY 29 0.0027
313 HAND FRACTURE 19 0.0027
314 PRESYNCOPE 65 0.0027
315 TREMOR 443 0.0027
316 PRODUCT SUPPLY ISSUE 19 0.0027
317 HEMIPARESIS 45 0.0027
318 INJURY ASSOCIATED WITH DEVICE 54 0.0026
319 MYDRIASIS 34 0.0026
320 EYE MOVEMENT DISORDER 18 0.0026
321 SINUS DISORDER 52 0.0026
322 EAR PAIN 51 0.0026
323 THERAPEUTIC RESPONSE SHORTENED 87 0.0026
324 UPPER RESPIRATORY TRACT INFECTION 121 0.0026
325 SPINAL OSTEOARTHRITIS 23 0.0026
326 OBSESSIVE-COMPULSIVE DISORDER 21 0.0026
327 RESPIRATION ABNORMAL 18 0.0026
328 PRODUCT TASTE ABNORMAL 35 0.0026
329 WEIGHT FLUCTUATION 27 0.0026
330 CONTUSION 248 0.0026
331 INTENTIONAL SELF-INJURY 52 0.0026
332 DRY THROAT 26 0.0026
333 UNRESPONSIVE TO STIMULI 66 0.0026
334 ANAL INCONTINENCE 23 0.0026
335 HYPERAESTHESIA 21 0.0026
336 FEELING HOT 156 0.0025
337 CHOLECYSTECTOMY 29 0.0025
338 MUSCULOSKELETAL STIFFNESS 222 0.0025
339 FOOT FRACTURE 48 0.0025
340 SPUTUM DISCOLOURED 24 0.0025
341 IMPAIRED WORK ABILITY 54 0.0025
342 HYPOAESTHESIA ORAL 38 0.0025
343 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 179 0.0025
344 SCAR 43 0.0025
345 MOOD SWINGS 80 0.0025
346 MALNUTRITION 28 0.0025
347 KIDNEY INFECTION 49 0.0025
348 MULTIPLE SCLEROSIS RELAPSE 171 0.0025
349 IRRITABILITY 150 0.0025
350 INTENTIONAL DOSE OMISSION 71 0.0025
351 DYSKINESIA 101 0.0025
352 ANGINA PECTORIS 71 0.0025
353 CONTRAINDICATED PRODUCT ADMINISTERED 75 0.0025
354 MEMORY IMPAIRMENT 340 0.0025
355 DIZZINESS 1226 0.0025
356 FLANK PAIN 23 0.0025
357 RENAL PAIN 26 0.0025
358 HEAVY MENSTRUAL BLEEDING 22 0.0024
359 ABNORMAL FAECES 20 0.0024
360 SENSITIVE SKIN 18 0.0024
361 ILLNESS 251 0.0024
362 NERVE INJURY 27 0.0024
363 MUSCLE STRAIN 21 0.0024
364 HYPERLIPIDAEMIA 29 0.0024
365 AFFECTIVE DISORDER 19 0.0024
366 DYSGEUSIA 179 0.0024
367 HYPERTENSION 510 0.0024
368 WITHDRAWAL SYNDROME 101 0.0024
369 TENDERNESS 25 0.0024
370 NASAL DISCOMFORT 19 0.0024
371 BREAST MASS 16 0.0024
372 CLOSTRIDIUM DIFFICILE INFECTION 52 0.0024
373 MUSCULOSKELETAL DISCOMFORT 41 0.0024
374 IRRITABLE BOWEL SYNDROME 51 0.0024
375 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
376 INJECTION SITE DISCOMFORT 25 0.0024
377 ORAL DISCOMFORT 33 0.0024
378 ANAPHYLACTIC REACTION 131 0.0024
379 FLUSHING 241 0.0024
380 DEPRESSED MOOD 125 0.0024
381 FEELING ABNORMAL 565 0.0024
382 PRODUCT USE COMPLAINT 37 0.0023
383 C-REACTIVE PROTEIN INCREASED 85 0.0023
384 LIGAMENT SPRAIN 23 0.0023
385 JOINT STIFFNESS 61 0.0023
386 EMBEDDED DEVICE 23 0.0023
387 PARANOIA 40 0.0023
388 SKIN INFECTION 26 0.0023
389 BALANCE DISORDER 200 0.0023
390 CRYING 84 0.0023
391 SURGERY 135 0.0023
392 DEVICE DELIVERY SYSTEM ISSUE 63 0.0023
393 NAUSEA 1820 0.0023
394 GALLBLADDER DISORDER 41 0.0023
395 VISION BLURRED 315 0.0023
396 JOINT INJURY 49 0.0023
397 IMPAIRED DRIVING ABILITY 26 0.0023
398 INTERVERTEBRAL DISC PROTRUSION 50 0.0023
399 ASPIRATION 25 0.0023
400 SUNBURN 17 0.0023
401 AGITATION 167 0.0023
402 MULTIPLE SCLEROSIS 108 0.0023
403 SENSATION OF FOREIGN BODY 19 0.0023
404 SEIZURE 260 0.0022
405 DRUG INTERACTION 357 0.0022
406 ATRIOVENTRICULAR BLOCK COMPLETE 15 0.0022
407 TUBULOINTERSTITIAL NEPHRITIS 42 0.0022
408 RHINITIS 18 0.0022
409 HALLUCINATION 168 0.0022
410 OCULAR DISCOMFORT 25 0.0022
411 DERMATITIS ALLERGIC 28 0.0022
412 VITAMIN D DECREASED 19 0.0022
413 DISORIENTATION 88 0.0022
414 THERAPEUTIC PRODUCT EFFECT DECREASED 99 0.0022
415 CONFUSIONAL STATE 356 0.0022
416 PSYCHOLOGICAL TRAUMA 19 0.0022
417 LOSS OF CONSCIOUSNESS 282 0.0022
418 TOOTH INFECTION 29 0.0022
419 DRUG INEFFECTIVE 2896 0.0022
420 EXOSTOSIS 20 0.0022
421 PRODUCT DOSE OMISSION IN ERROR 62 0.0022
422 RESPIRATORY TRACT INFECTION 57 0.0022
423 HEAD INJURY 69 0.0022
424 DEAFNESS 57 0.0022
425 MYALGIA 370 0.0022
426 GASTROINTESTINAL INFLAMMATION 17 0.0022
427 NERVE COMPRESSION 20 0.0022
428 DIZZINESS POSTURAL 21 0.0022
429 LARGE INTESTINE PERFORATION 15 0.0022
430 ARTHROPOD BITE 16 0.0022
431 COMPLICATION OF DEVICE REMOVAL 39 0.0022
432 SPEECH DISORDER 113 0.0022
433 PRODUCT DOSE OMISSION 139 0.0021
434 ANGER 72 0.0021
435 NASAL CONGESTION 125 0.0021
436 RENAL INJURY 63 0.0021
437 TASTE DISORDER 43 0.0021
438 SKIN LACERATION 23 0.0021
439 OVARIAN CYST 21 0.0021
440 LIMB INJURY 57 0.0021
441 URINARY RETENTION 70 0.0021
442 INCREASED APPETITE 40 0.0021
443 INJECTION SITE BRUISING 167 0.0021
444 MUSCLE RIGIDITY 25 0.0021
445 MATERNAL DRUGS AFFECTING FOETUS 16 0.0021
446 QUALITY OF LIFE DECREASED 28 0.0021
447 VOMITING 978 0.0021
448 INJECTION SITE URTICARIA 51 0.0021
449 EXPIRED PRODUCT ADMINISTERED 69 0.0021
450 DERMATITIS BULLOUS 15 0.0021
451 THIRST 37 0.0021
452 THERAPY NON-RESPONDER 93 0.0021
453 TREATMENT FAILURE 171 0.0021
454 TOOTH ABSCESS 21 0.0021
455 PREMATURE BABY 62 0.0021
456 BRAIN OEDEMA 26 0.0021
457 APNOEA 16 0.0021
458 BURNING SENSATION 144 0.0021
459 INFLUENZA LIKE ILLNESS 169 0.0021
460 AUTOIMMUNE DISORDER 20 0.0020
461 ORAL CANDIDIASIS 27 0.0020
462 DISCOMFORT 125 0.0020
463 INSOMNIA 545 0.0020
464 DEVICE MECHANICAL ISSUE 28 0.0020
465 RENAL TUBULAR NECROSIS 20 0.0020
466 TACHYCARDIA 181 0.0020
467 EYE INFECTION 23 0.0020
468 POOR VENOUS ACCESS 21 0.0020
469 MUSCLE SPASMS 372 0.0020
470 URINARY INCONTINENCE 60 0.0020
471 HYPERSOMNIA 58 0.0020
472 DISABILITY 40 0.0020
473 PRODUCT PRESCRIBING ERROR 48 0.0020
474 OROPHARYNGEAL PAIN 186 0.0020
475 DYSPEPSIA 197 0.0020
476 HEART RATE INCREASED 198 0.0020
477 ABDOMINAL PAIN 464 0.0020
478 FEELING JITTERY 38 0.0020
479 DENTAL CARIES 22 0.0020
480 FRUSTRATION TOLERANCE DECREASED 16 0.0020
481 BEDRIDDEN 26 0.0020
482 MUSCULAR WEAKNESS 224 0.0020
483 COMPLETED SUICIDE 164 0.0020
484 HEART RATE DECREASED 69 0.0020
485 SLUGGISHNESS 20 0.0020
486 PAIN 1203 0.0020
487 FATIGUE 1524 0.0020
488 NIGHT SWEATS 63 0.0020
489 CANDIDA INFECTION 33 0.0020
490 MOOD ALTERED 53 0.0019
491 INJECTION SITE HAEMORRHAGE 155 0.0019
492 PHARYNGITIS STREPTOCOCCAL 21 0.0019
493 RESTLESSNESS 71 0.0019
494 TOOTHACHE 35 0.0019
495 BACK INJURY 21 0.0019
496 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 15 0.0019
497 EXPOSURE VIA SKIN CONTACT 50 0.0019
498 APPENDICITIS 18 0.0019
499 EATING DISORDER 41 0.0019
500 DRY EYE 96 0.0019
501 OSTEOPOROSIS 79 0.0019
502 SYNCOPE 191 0.0019
503 SLEEP DISORDER 134 0.0019
504 BLOOD POTASSIUM DECREASED 57 0.0019
505 SKIN ULCER 49 0.0019
506 AMNESIA 123 0.0019
507 LOW BIRTH WEIGHT BABY 15 0.0019
508 URINARY TRACT INFECTION 322 0.0019
509 DYSMENORRHOEA 25 0.0019
510 GASTROENTERITIS VIRAL 34 0.0019
511 EMOTIONAL DISORDER 58 0.0019
512 LOWER LIMB FRACTURE 36 0.0019
513 ACCIDENTAL EXPOSURE TO PRODUCT 193 0.0019
514 BRADYCARDIA 99 0.0019
515 SUBARACHNOID HAEMORRHAGE 19 0.0019
516 PRESCRIBED UNDERDOSE 37 0.0019
517 HIATUS HERNIA 24 0.0019
518 INCREASED TENDENCY TO BRUISE 17 0.0018
519 CHOLECYSTITIS 22 0.0018
520 METABOLIC ACIDOSIS 59 0.0018
521 URTICARIA 309 0.0018
522 LETHARGY 106 0.0018
523 BLOOD PRESSURE INCREASED 280 0.0018
524 SUICIDE ATTEMPT 111 0.0018
525 SNEEZING 41 0.0018
526 THROAT IRRITATION 82 0.0018
527 DRY MOUTH 148 0.0018
528 LEUKOCYTOSIS 33 0.0018
529 PSORIASIS 238 0.0018
530 BLADDER DISORDER 18 0.0018
531 INABILITY TO AFFORD MEDICATION 18 0.0018
532 ABORTION INDUCED 17 0.0018
533 PRODUCT USE IN UNAPPROVED INDICATION 447 0.0018
534 HEMIPLEGIA 15 0.0018
535 INJECTION SITE PAIN 553 0.0018
536 ARTHRALGIA 749 0.0018
537 INCONTINENCE 19 0.0018
538 APPLICATION SITE ERYTHEMA 47 0.0018
539 SEXUAL DYSFUNCTION 21 0.0018
540 CONDITION AGGRAVATED 543 0.0018
541 MEDICATION ERROR 99 0.0018
542 ACUTE KIDNEY INJURY 271 0.0018
543 APPLICATION SITE IRRITATION 22 0.0018
544 ACUTE RESPIRATORY FAILURE 34 0.0018
545 RESPIRATORY TRACT CONGESTION 28 0.0018
546 CIRCULATORY COLLAPSE 30 0.0018
547 HERNIA 34 0.0018
548 AGGRESSION 88 0.0018
549 VENTRICULAR TACHYCARDIA 29 0.0018
550 POISONING 22 0.0017
551 INJECTION SITE SWELLING 134 0.0017
552 RETCHING 37 0.0017
553 IRON DEFICIENCY ANAEMIA 16 0.0017
554 COELIAC DISEASE 17 0.0017
555 RENAL FAILURE 230 0.0017
556 INJECTION SITE PRURITUS 116 0.0017
557 COVID-19 303 0.0017
558 VISUAL IMPAIRMENT 214 0.0017
559 FEEDING DISORDER 35 0.0017
560 INTENTIONAL OVERDOSE 110 0.0017
561 WEIGHT INCREASED 382 0.0017
562 BACK PAIN 396 0.0017
563 MANIA 28 0.0017
564 CONSTIPATION 370 0.0017
565 ABDOMINAL PAIN UPPER 349 0.0017
566 PROCEDURAL PAIN 47 0.0017
567 DYSPNOEA 956 0.0017
568 RHINORRHOEA 109 0.0017
569 GASTRIC ULCER 32 0.0017
570 ROAD TRAFFIC ACCIDENT 70 0.0017
571 BLOOD PRESSURE FLUCTUATION 40 0.0017
572 BACK DISORDER 27 0.0017
573 DIVERTICULITIS 46 0.0017
574 HALLUCINATION, VISUAL 35 0.0017
575 ABDOMINAL DISTENSION 173 0.0017
576 SINUS BRADYCARDIA 16 0.0017
577 DYSPHAGIA 157 0.0017
578 OSTEOARTHRITIS 70 0.0016
579 ALOPECIA 324 0.0016
580 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 28 0.0016
581 BURSITIS 20 0.0016
582 NOCTURIA 20 0.0016
583 DYSSTASIA 48 0.0016
584 ORAL HERPES 32 0.0016
585 MADAROSIS 19 0.0016
586 TOOTH FRACTURE 18 0.0016
587 CAESAREAN SECTION 19 0.0016
588 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
589 DECREASED IMMUNE RESPONSIVENESS 16 0.0016
590 BLOOD THYROID STIMULATING HORMONE INCREASED 15 0.0016
591 VITREOUS FLOATERS 16 0.0016
592 NERVOUSNESS 85 0.0016
593 BODY TEMPERATURE DECREASED 16 0.0016
594 PSYCHOTIC DISORDER 48 0.0016
595 SMALL INTESTINAL OBSTRUCTION 20 0.0016
596 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 78 0.0016
597 INTENTIONAL PRODUCT USE ISSUE 142 0.0016
598 MUSCULOSKELETAL CHEST PAIN 25 0.0016
599 MOUTH ULCERATION 34 0.0016
600 PULMONARY MASS 24 0.0016
601 MENTAL DISORDER 70 0.0016
602 FALL 535 0.0016
603 CORONARY ARTERY OCCLUSION 22 0.0016
604 MALAISE 700 0.0016
605 ANKYLOSING SPONDYLITIS 21 0.0016
606 HEART RATE IRREGULAR 36 0.0016
607 PRODUCTIVE COUGH 76 0.0016
608 EMOTIONAL DISTRESS 192 0.0016
609 MUSCULOSKELETAL PAIN 83 0.0016
610 WEIGHT DECREASED 442 0.0016
611 POLLAKIURIA 66 0.0016
612 DRUG EFFECT DECREASED 85 0.0016
613 APHONIA 22 0.0016
614 ULCER 25 0.0016
615 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0016
616 MYOCARDITIS 18 0.0016
617 ADVERSE DRUG REACTION 141 0.0016
618 SCIATICA 25 0.0016
619 PRODUCT PRESCRIBING ISSUE 34 0.0016
620 SKIN DISORDER 52 0.0016
621 LYMPHOPENIA 22 0.0016
622 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
623 ABDOMINAL DISCOMFORT 259 0.0015
624 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
625 DYSPNOEA EXERTIONAL 58 0.0015
626 HAEMORRHAGE INTRACRANIAL 23 0.0015
627 ACUTE HEPATIC FAILURE 21 0.0015
628 FLUID RETENTION 78 0.0015
629 INFLUENZA 171 0.0015
630 INJECTION SITE RASH 47 0.0015
631 ACCIDENTAL OVERDOSE 56 0.0015
632 OEDEMA 83 0.0015
633 PSORIATIC ARTHROPATHY 62 0.0015
634 MENTAL IMPAIRMENT 37 0.0015
635 MOVEMENT DISORDER 49 0.0015
636 GAIT INABILITY 51 0.0015
637 PERIPHERAL SWELLING 235 0.0015
638 NASOPHARYNGITIS 281 0.0015
639 RESPIRATORY ARREST 42 0.0015
640 INJURY 107 0.0015
641 IMMUNE SYSTEM DISORDER 20 0.0015
642 BLOOD IRON DECREASED 18 0.0015
643 SARS-COV-2 TEST POSITIVE 20 0.0015
644 INJECTION SITE MASS 56 0.0015
645 BLOOD PRESSURE ABNORMAL 30 0.0015
646 APATHY 22 0.0015
647 DRUG DOSE OMISSION 249 0.0015
648 HEPATIC STEATOSIS 28 0.0015
649 DEVICE BREAKAGE 61 0.0015
650 HAEMATEMESIS 38 0.0015
651 HAIR TEXTURE ABNORMAL 20 0.0015
652 CHOLELITHIASIS 49 0.0015
653 INJECTION SITE IRRITATION 19 0.0015
654 TENDONITIS 23 0.0015
655 PRODUCT ADMINISTRATION ERROR 30 0.0015
656 CHILLS 174 0.0015
657 INJECTION SITE ERYTHEMA 184 0.0015
658 JOINT SWELLING 179 0.0015
659 NEUROPATHY PERIPHERAL 141 0.0015
660 PAIN IN EXTREMITY 436 0.0015
661 SKIN DISCOLOURATION 68 0.0015
662 PRURITUS 568 0.0015
663 ORAL PAIN 33 0.0015
664 LYMPHADENOPATHY 52 0.0015
665 UNEVALUABLE EVENT 111 0.0015
666 DEPRESSED LEVEL OF CONSCIOUSNESS 58 0.0015
667 GINGIVAL BLEEDING 20 0.0015
668 CYANOSIS 23 0.0015
669 POST PROCEDURAL COMPLICATION 28 0.0015
670 INJECTION SITE REACTION 100 0.0015
671 APPLICATION SITE PAIN 32 0.0015
672 CYST 18 0.0014
673 INCORRECT DOSE ADMINISTERED BY DEVICE 38 0.0014
674 ILEUS 18 0.0014
675 PREGNANCY 29 0.0014
676 BLINDNESS 59 0.0014
677 HYPOKINESIA 21 0.0014
678 PETECHIAE 15 0.0014
679 EYE SWELLING 53 0.0014
680 ABDOMINAL PAIN LOWER 36 0.0014
681 ACCIDENT 17 0.0014
682 SKIN LESION 39 0.0014
683 SWELLING 133 0.0014
684 BONE PAIN 83 0.0014
685 SKIN HAEMORRHAGE 21 0.0014
686 WHEEZING 84 0.0014
687 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
688 LYMPHOCYTE COUNT DECREASED 25 0.0014
689 FUNGAL INFECTION 47 0.0014
690 INJECTION SITE WARMTH 29 0.0014
691 HYPOTHYROIDISM 45 0.0014
692 GASTRITIS 37 0.0014
693 MYOCARDIAL ISCHAEMIA 16 0.0014
694 SCAB 16 0.0014
695 GLAUCOMA 27 0.0014
696 DEEP VEIN THROMBOSIS 91 0.0014
697 BLOOD PRESSURE DECREASED 93 0.0014
698 OFF LABEL USE 1224 0.0014
699 THINKING ABNORMAL 26 0.0014
700 STAPHYLOCOCCAL INFECTION 46 0.0014
701 SKIN CANCER 30 0.0014
702 CEREBRAL INFARCTION 34 0.0014
703 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
704 ASTHENIA 521 0.0014
705 VIRAL INFECTION 46 0.0014
706 NODULE 18 0.0014
707 PULMONARY EMBOLISM 131 0.0014
708 DIARRHOEA 889 0.0014
709 DRUG EFFECT INCOMPLETE 50 0.0014
710 FEAR 37 0.0014
711 RASH MACULAR 48 0.0014
712 COLITIS 52 0.0014
713 GAIT DISTURBANCE 262 0.0014
714 HUNGER 19 0.0014
715 THYROID DISORDER 21 0.0014
716 HAEMATOCRIT DECREASED 27 0.0014
717 DEHYDRATION 181 0.0014
718 ECZEMA 71 0.0014
719 UPPER LIMB FRACTURE 27 0.0014
720 BLOOD CHOLESTEROL INCREASED 63 0.0014
721 LIVER FUNCTION TEST INCREASED 29 0.0013
722 GASTROINTESTINAL DISORDER 121 0.0013
723 THERAPY PARTIAL RESPONDER 21 0.0013
724 EPILEPSY 41 0.0013
725 DYSTONIA 26 0.0013
726 MACULAR DEGENERATION 16 0.0013
727 VAGINAL HAEMORRHAGE 58 0.0013
728 DYSURIA 49 0.0013
729 UVEITIS 18 0.0013
730 PSYCHOMOTOR HYPERACTIVITY 22 0.0013
731 INTENTIONAL PRODUCT MISUSE 116 0.0013
732 ACCIDENTAL UNDERDOSE 19 0.0013
733 AKATHISIA 18 0.0013
734 ANAPHYLACTIC SHOCK 34 0.0013
735 DEVICE LEAKAGE 57 0.0013
736 TOXICITY TO VARIOUS AGENTS 221 0.0013
737 INJECTION SITE HAEMATOMA 19 0.0013
738 MOBILITY DECREASED 94 0.0013
739 CARDIAC ARREST 108 0.0013
740 DECREASED APPETITE 300 0.0013
741 ELECTROLYTE IMBALANCE 15 0.0013
742 BASAL CELL CARCINOMA 20 0.0013
743 NERVOUS SYSTEM DISORDER 40 0.0013
744 INJECTION SITE DISCOLOURATION 16 0.0013
745 SPINAL PAIN 15 0.0013
746 IMMUNODEFICIENCY 19 0.0013
747 DRUG ABUSE 106 0.0013
748 RHABDOMYOLYSIS 53 0.0013
749 COVID-19 PNEUMONIA 15 0.0013
750 STOMATITIS 77 0.0013
751 DRUG LEVEL INCREASED 21 0.0013
752 SYSTEMIC LUPUS ERYTHEMATOSUS 45 0.0013
753 MUSCLE ATROPHY 16 0.0013
754 PNEUMOTHORAX 20 0.0013
755 COUGH 353 0.0013
756 LACRIMATION INCREASED 38 0.0013
757 CARDIOGENIC SHOCK 18 0.0013
758 PNEUMONIA 406 0.0013
759 HERPES ZOSTER 72 0.0013
760 HYPOPHAGIA 32 0.0013
761 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
762 HAEMATOCHEZIA 69 0.0012
763 EYE PRURITUS 42 0.0012
764 EYE DISORDER 41 0.0012
765 THERAPY CESSATION 64 0.0012
766 THERAPY INTERRUPTED 89 0.0012
767 FAECES DISCOLOURED 27 0.0012
768 RASH 542 0.0012
769 CHROMATURIA 28 0.0012
770 PRODUCT DISPENSING ERROR 27 0.0012
771 UNDERDOSE 90 0.0012
772 MENTAL STATUS CHANGES 34 0.0012
773 RESPIRATORY DEPRESSION 15 0.0012
774 DEVICE DIFFICULT TO USE 81 0.0012
775 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 219 0.0012
776 PULMONARY CONGESTION 16 0.0012
777 EXTRA DOSE ADMINISTERED 49 0.0012
778 MUSCULOSKELETAL DISORDER 23 0.0012
779 DRUG ADMINISTRATION ERROR 37 0.0012
780 SYRINGE ISSUE 21 0.0012
781 MALIGNANT MELANOMA 16 0.0012
782 BRONCHOSPASM 17 0.0012
783 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 62 0.0012
784 BONE DENSITY DECREASED 37 0.0012
785 DRUG DISPENSING ERROR 18 0.0012
786 DISEASE RECURRENCE 56 0.0012
787 HYPOTENSION 236 0.0012
788 GOUT 21 0.0012
789 PYREXIA 403 0.0012
790 ABNORMAL DREAMS 32 0.0012
791 IMPAIRED HEALING 38 0.0012
792 PELVIC PAIN 21 0.0012
793 PAIN OF SKIN 31 0.0012
794 INFECTION 166 0.0011
795 LOWER RESPIRATORY TRACT INFECTION 52 0.0011
796 ENCEPHALOPATHY 28 0.0011
797 BLISTER 64 0.0011
798 PALLOR 31 0.0011
799 DERMATITIS ATOPIC 60 0.0011
800 DEVICE OCCLUSION 16 0.0011
801 MYOCARDIAL INFARCTION 198 0.0011
802 OEDEMA PERIPHERAL 138 0.0011
803 INFLAMMATION 58 0.0011
804 RENAL DISORDER 52 0.0011
805 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 226 0.0011
806 INTESTINAL OBSTRUCTION 42 0.0011
807 SINUS CONGESTION 15 0.0011
808 WOUND 31 0.0011
809 THROMBOSIS 89 0.0011
810 HYPOKALAEMIA 51 0.0011
811 DEVICE RELATED INFECTION 17 0.0011
812 COMPLICATION ASSOCIATED WITH DEVICE 16 0.0011
813 SPINAL FRACTURE 22 0.0011
814 GASTROENTERITIS 16 0.0011
815 PRODUCT USE ISSUE 206 0.0011
816 DELUSION 17 0.0011
817 KNEE ARTHROPLASTY 23 0.0011
818 ERYTHEMA 224 0.0011
819 RASH PRURITIC 59 0.0011
820 CARDIOMYOPATHY 16 0.0011
821 LEUKOPENIA 54 0.0011
822 TOOTH DISORDER 24 0.0011
823 PANCREATITIS 57 0.0011
824 DRUG ERUPTION 19 0.0011
825 CELLULITIS 54 0.0011
826 RASH PAPULAR 24 0.0011
827 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 36 0.0011
828 HIP FRACTURE 34 0.0011
829 EPISTAXIS 79 0.0011
830 PRODUCT AVAILABILITY ISSUE 24 0.0011
831 PROTEINURIA 20 0.0011
832 DERMATITIS 22 0.0010
833 RED BLOOD CELL COUNT DECREASED 30 0.0010
834 HIP ARTHROPLASTY 16 0.0010
835 BONE DISORDER 19 0.0010
836 TREATMENT NONCOMPLIANCE 57 0.0010
837 HYPERTHYROIDISM 15 0.0010
838 MULTIPLE FRACTURES 17 0.0010
839 LOCALISED INFECTION 25 0.0010
840 ORTHOSTATIC HYPOTENSION 18 0.0010
841 DEVICE USE ISSUE 18 0.0010
842 CHOKING 20 0.0010
843 CONJUNCTIVITIS 19 0.0010
844 PANCREATITIS ACUTE 23 0.0010
845 HYPOXIA 36 0.0010
846 RHEUMATOID ARTHRITIS 116 0.0010
847 BLOOD UREA INCREASED 17 0.0010
848 RESPIRATORY DISTRESS 28 0.0010
849 APPLICATION SITE PRURITUS 23 0.0010
850 HEPATIC ENZYME INCREASED 69 0.0010
851 INFUSION RELATED REACTION 67 0.0010
852 ABNORMAL BEHAVIOUR 40 0.0010
853 MENSTRUATION IRREGULAR 27 0.0010
854 HALLUCINATION, AUDITORY 16 0.0010
855 CONVULSION 57 0.0010
856 LIVER DISORDER 44 0.0010
857 GASTRIC DISORDER 34 0.0010
858 INCORRECT DOSE ADMINISTERED 226 0.0010
859 SEPSIS 110 0.0010
860 RASH ERYTHEMATOUS 47 0.0010
861 OVERDOSE 212 0.0010
862 PRESCRIBED OVERDOSE 19 0.0010
863 LUNG DISORDER 48 0.0010
864 DEVICE USE ERROR 34 0.0010
865 HAEMORRHOIDS 19 0.0010
866 SKIN FISSURES 19 0.0010
867 PRODUCT STORAGE ERROR 85 0.0010
868 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
869 HYPOGLYCAEMIA 47 0.0010
870 BACTERIAL INFECTION 18 0.0010
871 PULMONARY HYPERTENSION 20 0.0010
872 INTENTIONAL DRUG MISUSE 20 0.0010
873 COMPLICATION OF DEVICE INSERTION 19 0.0010
874 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
875 PERICARDIAL EFFUSION 22 0.0010
876 BLOOD URINE PRESENT 18 0.0009
877 STEVENS-JOHNSON SYNDROME 21 0.0009
878 FULL BLOOD COUNT DECREASED 19 0.0009
879 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
880 WHITE BLOOD CELL COUNT DECREASED 100 0.0009
881 TOOTH LOSS 19 0.0009
882 SHOCK 21 0.0009
883 EYE IRRITATION 52 0.0009
884 VISUAL ACUITY REDUCED 30 0.0009
885 HYPOCALCAEMIA 17 0.0009
886 HAEMOPTYSIS 25 0.0009
887 DRUG DOSE OMISSION BY DEVICE 70 0.0009
888 TYPE 2 DIABETES MELLITUS 30 0.0009
889 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
890 DRUG EXPOSURE DURING PREGNANCY 30 0.0009
891 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 16 0.0009
892 PULMONARY OEDEMA 39 0.0009
893 RESPIRATORY DISORDER 26 0.0009
894 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
895 FLATULENCE 49 0.0009
896 DRUG-INDUCED LIVER INJURY 27 0.0009
897 LOCAL SWELLING 15 0.0009
898 CORONARY ARTERY DISEASE 26 0.0009
899 ACTIVITIES OF DAILY LIVING IMPAIRED 17 0.0009
900 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
901 ABASIA 21 0.0008
902 GLOSSODYNIA 19 0.0008
903 ADVERSE EVENT 78 0.0008
904 OCULAR HYPERAEMIA 40 0.0008
905 HOSPITALISATION 129 0.0008
906 RECTAL HAEMORRHAGE 36 0.0008
907 PRURITUS GENERALISED 18 0.0008
908 SKIN EXFOLIATION 70 0.0008
909 PRODUCT PREPARATION ERROR 17 0.0008
910 CEREBROVASCULAR ACCIDENT 140 0.0008
911 DRUG RESISTANCE 21 0.0008
912 ASCITES 24 0.0008
913 FREQUENT BOWEL MOVEMENTS 22 0.0008
914 DIABETES MELLITUS 62 0.0008
915 AGRANULOCYTOSIS 15 0.0008
916 ARRHYTHMIA 38 0.0008
917 HEPATIC CIRRHOSIS 15 0.0008
918 BLOOD CREATININE INCREASED 52 0.0008
919 BLOOD SODIUM DECREASED 15 0.0008
920 GENERAL PHYSICAL HEALTH DETERIORATION 91 0.0008
921 RENAL IMPAIRMENT 66 0.0008
922 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
923 HEPATITIS 20 0.0008
924 ACNE 59 0.0008
925 CATARACT 46 0.0008
926 DRY SKIN 103 0.0008
927 OXYGEN SATURATION DECREASED 43 0.0008
928 COLITIS ULCERATIVE 34 0.0008
929 DRUG DEPENDENCE 121 0.0008
930 LABORATORY TEST ABNORMAL 22 0.0007
931 HYPOACUSIS 32 0.0007
932 CARDIO-RESPIRATORY ARREST 31 0.0007
933 ILL-DEFINED DISORDER 45 0.0007
934 DRUG WITHDRAWAL SYNDROME 65 0.0007
935 ANAEMIA 141 0.0007
936 ARTHROPATHY 41 0.0007
937 CARDIAC DISORDER 69 0.0007
938 HAEMORRHAGE 77 0.0007
939 HAEMATOMA 19 0.0007
940 HAEMATURIA 25 0.0007
941 BLOOD GLUCOSE DECREASED 35 0.0007
942 CEREBRAL HAEMORRHAGE 26 0.0007
943 DELIRIUM 25 0.0007
944 PLEURAL EFFUSION 43 0.0007
945 THROMBOCYTOPENIA 79 0.0007
946 OSTEONECROSIS 23 0.0007
947 LIVER FUNCTION TEST ABNORMAL 20 0.0007
948 AGEUSIA 17 0.0007
949 SKIN BURNING SENSATION 48 0.0007
950 ERECTILE DYSFUNCTION 17 0.0007
951 PRODUCT ADHESION ISSUE 23 0.0006
952 INCORRECT ROUTE OF DRUG ADMINISTRATION 23 0.0006
953 INCORRECT DRUG ADMINISTRATION DURATION 18 0.0006
954 SKIN IRRITATION 29 0.0006
955 HAEMOGLOBIN DECREASED 65 0.0006
956 RESPIRATORY FAILURE 46 0.0006
957 CARDIOVASCULAR DISORDER 16 0.0006
958 HEPATIC FAILURE 19 0.0006
959 COMA 30 0.0006
960 DIABETIC KETOACIDOSIS 15 0.0006
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43 0.0006
962 HYPERGLYCAEMIA 22 0.0006
963 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
964 PNEUMONIA ASPIRATION 15 0.0006
965 JAUNDICE 16 0.0006
966 MUCOSAL INFLAMMATION 15 0.0006
967 ATRIAL FIBRILLATION 55 0.0006
968 NEUTROPHIL COUNT DECREASED 23 0.0006
969 BREAST CANCER FEMALE 15 0.0006
970 HYPONATRAEMIA 30 0.0005
971 NO ADVERSE EVENT 92 0.0005
972 DEVICE DISLOCATION 22 0.0005
973 SEPTIC SHOCK 22 0.0005
974 LACTIC ACIDOSIS 16 0.0005
975 PLATELET COUNT DECREASED 52 0.0005
976 FEMUR FRACTURE 15 0.0005
977 NEOPLASM MALIGNANT 31 0.0005
978 NEUTROPENIA 63 0.0005
979 BREAST CANCER 42 0.0005
980 BLOOD GLUCOSE INCREASED 83 0.0004
981 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
982 CARDIAC FAILURE CONGESTIVE 35 0.0004
983 RENAL FAILURE ACUTE 18 0.0004
984 FEBRILE NEUTROPENIA 28 0.0004
985 DEVICE EXPULSION 27 0.0004
986 MALIGNANT NEOPLASM PROGRESSION 37 0.0004
987 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
988 PANCYTOPENIA 20 0.0004
989 DISEASE PROGRESSION 39 0.0003
990 CARDIAC FAILURE 18 0.0002
991 DEATH 189 0.0002